IL130404A0 - Use of photodynamic therapy for prevention of secondary cataracts - Google Patents
Use of photodynamic therapy for prevention of secondary cataractsInfo
- Publication number
- IL130404A0 IL130404A0 IL13040497A IL13040497A IL130404A0 IL 130404 A0 IL130404 A0 IL 130404A0 IL 13040497 A IL13040497 A IL 13040497A IL 13040497 A IL13040497 A IL 13040497A IL 130404 A0 IL130404 A0 IL 130404A0
- Authority
- IL
- Israel
- Prior art keywords
- prevention
- photodynamic therapy
- secondary cataracts
- cataracts
- photodynamic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/762,854 US6043237A (en) | 1996-12-10 | 1996-12-10 | Use of photodynamic therapy for prevention of secondary cataracts |
PCT/CA1997/000949 WO1998025610A1 (en) | 1996-12-10 | 1997-12-08 | Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts |
Publications (1)
Publication Number | Publication Date |
---|---|
IL130404A0 true IL130404A0 (en) | 2000-06-01 |
Family
ID=25066203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13040497A IL130404A0 (en) | 1996-12-10 | 1997-12-08 | Use of photodynamic therapy for prevention of secondary cataracts |
Country Status (15)
Country | Link |
---|---|
US (2) | US6043237A (no) |
EP (1) | EP0948329A1 (no) |
JP (1) | JP2001505885A (no) |
KR (1) | KR20000057510A (no) |
CN (1) | CN1246054A (no) |
AR (1) | AR010754A1 (no) |
AU (1) | AU737204B2 (no) |
CA (1) | CA2273010C (no) |
HU (1) | HUP0000576A3 (no) |
IL (1) | IL130404A0 (no) |
NO (1) | NO992808L (no) |
NZ (1) | NZ336196A (no) |
PL (1) | PL333951A1 (no) |
WO (1) | WO1998025610A1 (no) |
ZA (1) | ZA9711104B (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0963196B1 (en) * | 1996-09-27 | 2005-01-19 | Jagotec Ag | Hyaluronic drug delivery system |
ES2237146T3 (es) | 1998-08-28 | 2005-07-16 | Destiny Pharma Limited | Derivados de porfirina, su uso en terapia fotodinamica y dispositivos medicos que los contienen. |
US6828439B1 (en) | 1999-02-26 | 2004-12-07 | Advanced Research And Technology Institute, Inc. | Compounds, composition, and methods for photodynamic therapy |
US7022843B1 (en) | 1999-04-14 | 2006-04-04 | The University Of British Columbia | β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins |
US6319273B1 (en) * | 1999-12-16 | 2001-11-20 | Light Sciences Corporation | Illuminating device for treating eye disease |
US6673067B1 (en) * | 2000-01-31 | 2004-01-06 | Gholam A. Peyman | System and method for thermally and chemically treating cells at sites of interest in the body to impede cell proliferation |
US7193706B2 (en) * | 2000-08-02 | 2007-03-20 | Arizona Board Of Regents, Acting On Behalf Of Arizona State University | Computer interfaced scanning fluorescence lifetime microscope applied to directed evolution |
US6514995B1 (en) | 2000-09-25 | 2003-02-04 | Advanced Research And Technology Institute, Inc. | Enediyne compounds and methods related thereto |
US7211603B1 (en) | 2000-09-25 | 2007-05-01 | Indiana University Research And Technology Corporation | Enediyne compounds and methods related thereto |
US7169755B2 (en) * | 2000-12-20 | 2007-01-30 | Alcon, Inc. | Solution for removing cataracts via liquefracture |
US7753943B2 (en) * | 2001-02-06 | 2010-07-13 | Qlt Inc. | Reduced fluence rate PDT |
US8106038B2 (en) | 2001-02-15 | 2012-01-31 | Qlt Inc. | Method for reducing or preventing PDT related inflammation |
US6838074B2 (en) | 2001-08-08 | 2005-01-04 | Bristol-Myers Squibb Company | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
EP1465590B1 (en) * | 2001-11-02 | 2008-03-26 | The Governors Of The University Of Alberta | Micelle compositions containing pegylated phospholipids and a photosensitizer |
US6723750B2 (en) | 2002-03-15 | 2004-04-20 | Allergan, Inc. | Photodynamic therapy for pre-melanomas |
JP4468810B2 (ja) | 2002-07-24 | 2010-05-26 | キューエルティー インコーポレーティッド | ピラゾリルベンゾチアゾール誘導体および治療薬としてのそれらの使用法 |
CA2500877A1 (en) * | 2002-10-03 | 2004-04-15 | Light Sciences Corporation | Excitation of photoreactive compounds in eye tissue |
EP1605847B1 (en) * | 2003-03-07 | 2009-09-16 | Board Of Regents, The University Of Texas System | Antibody-targeted photodynamic therapy |
US20050048109A1 (en) * | 2003-08-26 | 2005-03-03 | Ceramoptec Industries, Inc. | Non-polar photosensitizer formulations for photodynamic therapy |
US7252662B2 (en) * | 2004-11-02 | 2007-08-07 | Lenticular Research Group Llc | Apparatus and processes for preventing or delaying one or more symptoms of presbyopia |
US7468434B2 (en) * | 2004-12-22 | 2008-12-23 | The University Of Hong Kong | Diazene-bridge crown ether lithium compounds and methods for their use |
US9649224B2 (en) | 2005-02-19 | 2017-05-16 | Lenticular Research Group Llc | Apparatus and processes for preventing or delaying onset or progression of age-related cataract |
US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
EP2802302A4 (en) * | 2012-01-10 | 2015-09-23 | Avedro Inc | APPLYING ENERGY FOR MEDICAL TREATMENTS |
EP4420725A2 (en) | 2012-03-29 | 2024-08-28 | Epion Therapeutics, Inc. | Ocular treatment solutions, delivery devices and delivery augmentation methods |
EP2830554A1 (en) * | 2012-03-29 | 2015-02-04 | CXL Ophthalmics, LLC | Ocular cross-linking system and method for sealing corneal wounds |
WO2013149075A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Compositions and methods for treating or preventing diseases associated with oxidative stress |
CN106620893B (zh) | 2015-07-23 | 2021-07-30 | 爱博诺德(北京)医疗科技股份有限公司 | 用于眼部疾病光治疗的材料 |
US20230165718A1 (en) * | 2021-11-29 | 2023-06-01 | Alan Neil Glazier | Methods, devices, and systems for treating lens protein aggregation diseases |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202252A (en) * | 1982-03-05 | 1993-04-13 | Houston Biotechnology Inc. | Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
US5283255A (en) * | 1987-01-20 | 1994-02-01 | The University Of British Columbia | Wavelength-specific cytotoxic agents |
US5095030A (en) * | 1987-01-20 | 1992-03-10 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US5171749A (en) * | 1987-01-20 | 1992-12-15 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US4920143A (en) * | 1987-04-23 | 1990-04-24 | University Of British Columbia | Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents |
US5401880A (en) * | 1987-06-04 | 1995-03-28 | Oculon Corporation | Chemical prevention or reversal of cataract by phase separation inhibitors |
US4966577A (en) * | 1988-03-16 | 1990-10-30 | Allergan, Inc. | Prevention of lens-related tissue growth in the eye |
US5273751A (en) * | 1988-03-25 | 1993-12-28 | Seymour Dubroff | Composition for preventing clouding of paosterior capsule after extracapsular cataract eye surgery and method of performing cataract surgery |
US5375611A (en) * | 1993-01-26 | 1994-12-27 | Pharmacia Ab | Method for preventing secondary cataract |
US5422362A (en) * | 1993-07-29 | 1995-06-06 | Quadra Logic Technologies, Inc. | Method to inhibit restenosis |
US5445637A (en) * | 1993-12-06 | 1995-08-29 | American Cyanamid Company | Method and apparatus for preventing posterior capsular opacification |
AU6813694A (en) * | 1994-03-14 | 1995-10-03 | Massachusetts Eye & Ear Infirmary | Use of green porphyrins in ocular diagnosis and therapy |
US5798349A (en) * | 1994-03-14 | 1998-08-25 | The General Hospital Corporation | Use of green porphyrins to treat neovasculature in the eye |
-
1996
- 1996-12-10 US US08/762,854 patent/US6043237A/en not_active Expired - Lifetime
-
1997
- 1997-12-08 EP EP97946989A patent/EP0948329A1/en not_active Ceased
- 1997-12-08 WO PCT/CA1997/000949 patent/WO1998025610A1/en not_active Application Discontinuation
- 1997-12-08 IL IL13040497A patent/IL130404A0/xx unknown
- 1997-12-08 CA CA002273010A patent/CA2273010C/en not_active Expired - Lifetime
- 1997-12-08 JP JP52603998A patent/JP2001505885A/ja active Pending
- 1997-12-08 CN CN97180428A patent/CN1246054A/zh active Pending
- 1997-12-08 PL PL97333951A patent/PL333951A1/xx unknown
- 1997-12-08 NZ NZ336196A patent/NZ336196A/xx unknown
- 1997-12-08 KR KR1019990705200A patent/KR20000057510A/ko not_active Application Discontinuation
- 1997-12-08 HU HU0000576A patent/HUP0000576A3/hu unknown
- 1997-12-08 AU AU52202/98A patent/AU737204B2/en not_active Ceased
- 1997-12-10 ZA ZA9711104A patent/ZA9711104B/xx unknown
- 1997-12-10 AR ARP970105787A patent/AR010754A1/es not_active Application Discontinuation
-
1999
- 1999-06-09 NO NO992808A patent/NO992808L/no not_active Application Discontinuation
-
2000
- 2000-03-27 US US09/536,291 patent/US6248734B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AR010754A1 (es) | 2000-07-12 |
EP0948329A1 (en) | 1999-10-13 |
AU5220298A (en) | 1998-07-03 |
JP2001505885A (ja) | 2001-05-08 |
US6043237A (en) | 2000-03-28 |
NO992808L (no) | 1999-08-09 |
US6248734B1 (en) | 2001-06-19 |
AU737204B2 (en) | 2001-08-09 |
NO992808D0 (no) | 1999-06-09 |
WO1998025610A1 (en) | 1998-06-18 |
CA2273010C (en) | 2007-03-13 |
CN1246054A (zh) | 2000-03-01 |
NZ336196A (en) | 2000-10-27 |
ZA9711104B (en) | 1998-07-10 |
HUP0000576A3 (en) | 2002-09-30 |
CA2273010A1 (en) | 1998-06-18 |
PL333951A1 (en) | 2000-01-31 |
KR20000057510A (ko) | 2000-09-15 |
HUP0000576A2 (hu) | 2000-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9711104B (en) | Use of photodynamic therapy for prevention of secondary cataracts | |
AU2562797A (en) | Combination therapy for treatment of erectile dysfunction | |
GB2287652B (en) | Efficient photodynamic treatment | |
AU5424596A (en) | Microminiature illuminator for administering photodynamic therapy | |
EP0764030A4 (en) | USE OF AUTOANTIBODIES FOR ANTI-TUMOR THERAPY AND PROPHYLAXIS | |
AU4411297A (en) | Combination therapy for treatment of psychoses | |
ZA957879B (en) | Combination therapy for hypercholesterolemia | |
AP2002002661A0 (en) | Combination therapy for oesteoporosis | |
PL344977A1 (en) | Therapeutic uses of quinoline derivatives | |
PL330235A1 (en) | Derivatives of spiropiperidine and their application as therapeutic agents | |
EP1077704A4 (en) | COMBINATION THERAPY FOR TREATING DEPRESSION | |
EP1007028A4 (en) | TREATING GLAUCOMA WITH 8 ISO PROSTAGLANDINE | |
IL136515A0 (en) | Combination effective for the treatment of impotence | |
EP0959879A4 (en) | PHOTODYNAMIC THERAPY FOR THE TREATMENT OF ARTHROSIS | |
HUP9904617A3 (en) | Secondary cataract inhibitor | |
GB9808936D0 (en) | Combination therapy for the prevention and treatment of osteoporosis | |
AU6450398A (en) | Sr-bi regulatory sequences and therapeutic methods of use | |
AU3118697A (en) | Radiation therapy dose calculation engine | |
AU7105498A (en) | Combination therapy for the prevention and treatment of osteoporosis | |
GB9725114D0 (en) | Treatment of pruritus | |
IL135994A0 (en) | Combination therapy for the treatment of aids | |
IL130831A0 (en) | Imino-aza-anthracylinone derivatives for the treatment of amyloidosis | |
EP0878200A4 (en) | THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES | |
AU7985698A (en) | Methods for treatment of ocular neovascularization | |
GB2323284B (en) | Device for photodynamic therapy of pituitary tumours |